Blood-brain barrier disruption in diabetic mice is linked to Nrf2 signaling deficits: Role of ABCB10?

•In vivo fluorescence imaging revealed BBB hyper-permeability in diabetic mice.•Nrf2 is significantly down-regulated in diabetic brain.•Nrf2 regulates mitochondrial ABCB10 expression in human BBB endothelium.•Hyperglycemia markedly reduces ABCB10 expression in BBB endothelial cells.•Nrf2 or ABCB10 g...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience letters Vol. 653; pp. 152 - 158
Main Authors Sajja, Ravi K., Prasad, Shikha, Tang, Suni, Kaisar, Mohammad A., Cucullo, Luca
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 13.07.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•In vivo fluorescence imaging revealed BBB hyper-permeability in diabetic mice.•Nrf2 is significantly down-regulated in diabetic brain.•Nrf2 regulates mitochondrial ABCB10 expression in human BBB endothelium.•Hyperglycemia markedly reduces ABCB10 expression in BBB endothelial cells.•Nrf2 or ABCB10 gene silencing increases BBB endothelial-monocyte adhesion. Blood-brain barrier (BBB) damage is a critical neurovascular complication of diabetes mellitus that adversely affects the CNS health and function. Previously, we showed the protective role of NF-E2 related factor-2 (Nrf2), a redox sensitive transcription factor, in regulation of BBB integrity. Given the pathogenic role of mitochondrial oxidative stress in diabetes-related microvascular complications, we focused on assessing: 1) the impact of diabetes on brain Nrf2 in correlation with BBB permeability and 2) Nrf2-dependent regulation of the mitochondrial transporter ABCB10, an essential player in mitochondrial function and redox balance at BBB endothelium. Using live animal fluorescence imaging, we demonstrated a strong increase in BBB permeability to 70kDa dextran in db/db diabetic mice that correlated with significant down-regulation of brain Nrf2 protein. Further, Nrf2 gene silencing in human BBB endothelial cells markedly suppressed ABCB10 protein, while Nrf2 activation by sulforaphane up-regulated ABCB10 expression. Interestingly, ABCB10 knockdown resulted in a strong-induction of Nrf2 driven anti-oxidant responses as evidenced by increased expression of Nrf2 and its downstream targets. Nrf2 or ABCB10 silencing elevated endothelial-monocyte adhesion suggesting an activated inflammatory cascade. Thus, our results demonstrate a novel mechanism of ABCB10 regulation driven by Nrf2. In summary, Nrf2 dysregulation and ABCB10 suppression could likely mediate endothelial oxidative/inflammatory stress and BBB disruption in diabetic subjects.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current address: Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77030 USA
ISSN:0304-3940
1872-7972
1872-7972
DOI:10.1016/j.neulet.2017.05.059